These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3259580)

  • 1. Acellular pertussis vaccines: evaluation of reversion in a nude mouse model.
    Quentin-Millet MJ; Arminjon F; Danve B; Cadoz M; Armand J
    J Biol Stand; 1988 Apr; 16(2):99-108. PubMed ID: 3259580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the epinephrine-refractory hypoglycaemic activity of whole-cell pertussis vaccine in mice.
    Horiuchi Y; Iida T
    J Biol Stand; 1988 Oct; 16(4):239-48. PubMed ID: 3143732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acellular pertussis vaccine: immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18- to 24-month old children.
    Pichichero ME; Badgett JT; Rodgers GC; McLinn S; Trevino-Scatterday B; Nelson JD
    Pediatr Infect Dis J; 1987 Apr; 6(4):352-63. PubMed ID: 3495775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR; Gottshall RY; Nelsom E; Angela F
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and toxicity testing of pertussis vaccine.
    Kurokawa M
    Jpn J Med Sci Biol; 1984 Apr; 37(2):41-81. PubMed ID: 6207324
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
    Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
    N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of rat-paw oedema tests for assessing reactivity of B. pertussis-containing combined vaccines.
    Průchova J; Karel J; Vrána M; Elis J; Blazek Z
    Dev Biol Stand; 1986; 65():177-83. PubMed ID: 2881822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of a diphtheria-tetanus-pertussis vaccine containing an acellular pertussis component.
    Badgett JT; Rodgers GC
    South Med J; 1987 Sep; 80(9):1075-8. PubMed ID: 3498218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyrogenicity of pertussis vaccine in mice and the factors in the vaccine responsible for this effect.
    Ishida S; Iwasa S; Fujiwara H; Chazono M; Akama K
    J Biol Stand; 1989 Jan; 17(1):41-51. PubMed ID: 2784132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the toxicity of the pertussis component of the Di-Te-Per vaccine].
    Gołobów M; Kardymowicz B; Kudelski Z; Rymkiewicz D; Sawicki J
    Med Dosw Mikrobiol; 1986; 38(1):9-14. PubMed ID: 2423821
    [No Abstract]   [Full Text] [Related]  

  • 11. A placebo-controlled trial of a pertussis-toxoid vaccine.
    Trollfors B; Taranger J; Lagergård T; Lind L; Sundh V; Zackrisson G; Lowe CU; Blackwelder W; Robbins JB
    N Engl J Med; 1995 Oct; 333(16):1045-50. PubMed ID: 7675047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of the rat paw edema test for evaluating the reactivity of combined vaccines containing a pertussis component].
    Průchová J; Karel J; Vrána M; Elis J; Blazek Z
    Cesk Farm; 1988 Sep; 37(7):322-6. PubMed ID: 3264220
    [No Abstract]   [Full Text] [Related]  

  • 13. Swelling of the brain in mice caused by pertussis vaccine--its quantitative determination and the responsible factors in the vaccine.
    Iwasa S; Ishida S; Akama K
    Jpn J Med Sci Biol; 1985 Apr; 38(2):53-65. PubMed ID: 3878421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC; Sharma SB; Ahuja S; Saxena SN
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.
    Gustafsson L; Hallander HO; Olin P; Reizenstein E; Storsaeter J
    N Engl J Med; 1996 Feb; 334(6):349-55. PubMed ID: 8538705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA; Roberts PA
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS; Malivanova OM; Sokolovskaya AD; Shavrova EN; Kapustik LA
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(4):439-48. PubMed ID: 7320507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of combined diphtheria-tetanus-pertussis (whole cell and acellular)-Haemophilus influenzae-b conjugate vaccines administered to Indonesian children.
    Richie E; Punjabi NH; Harjanto SJ; Wangsasaputral F; Sukandar M; Supriatman M; Simanjuntak CH; Que JU; Cryz SJ
    Vaccine; 1999 Mar; 17(11-12):1384-93. PubMed ID: 10195774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pertussis toxin-induced alterations of murine hepatic drug metabolism following administration of diphtheria and tetanus toxoids and pertussis vaccine adsorbed.
    Ansher S; Thompson W; Bridgewater J; Snoy P
    Infect Immun; 1993 Oct; 61(10):4240-7. PubMed ID: 8406812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.